| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Sandoz A/S, +7 | 46,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Teva Denmark A/S, +5 | 284,6 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, +2 | 59,2 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 1.606.b | Amgros I/S | Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.1202.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, +3 | 381,7 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS | 75,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 2.1201.a | Amgros I/S | Paranova Danmark ApS, Orifarm Generics A/S, Pfizer ApS, Gedeon Richter Plc, Orifarm A/S, XGX Pharma ApS, +2 | 128,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, +9 | 899,2 mio. kr. (samlet) | 19.10.2026 |
| Amgros 2027 2.3.b | Amgros I/S | Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Macure Pharma ApS, Accord Healthcare AB, FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, +10 | 690,9 mio. kr. (samlet) | 19.10.2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Abacus Medicine A/S, 2care4 ApS, Orifarm A/S | 26,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, +6 | 148,1 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1205.b | Amgros I/S | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS | 44 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, AstraZeneca A/S | 44,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, +3 | 256,3 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, Orifarm A/S, Nordic Prime ApS | 51,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Aguettant Nordic ApS, Zentiva Denmark ApS, Øresund Pharma ApS, GE Healthcare A/S, +4 | 73,5 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, +9 | 419,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.702.b | Amgros I/S | Orifarm A/S, Abacus Medicine A/S | 3,9 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.1174.a | Amgros I/S | Orifarm A/S | 12,7 mio. kr. | 30.9.2026 |
| Amgros 2027 1.1051.b | Amgros I/S | 2care4 ApS, Orifarm A/S, Roche Pharmaceuticals A/S | 254 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, +3 | 704 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2026 1.164.a | Amgros I/S | Orifarm A/S, Abacus Medicine A/S | 3,2 mio. kr. (samlet) | 26.6.2026 |
| Amgros 2026 1.354.b | Amgros I/S | STADA Nordic ApS, Teva Denmark A/S, Accord Healthcare AB, Orifarm A/S | 8,9 mio. kr. (samlet) | 24.3.2026 |
| Amgros 2026 1.353.b | Amgros I/S | Pfizer ApS, Orifarm A/S, Sandoz A/S, 2care4 ApS, Biogen (Denmark) A/S, Celltrion Healthcare Denmark ApS, +10 | 2,3 mia. kr. (samlet) | 13.3.2026 |
| Amgros 2026 2.703.b | Amgros I/S | 2care4 Generics ApS, Paranova Danmark A/S, Orifarm A/S, Abcur AB, 2care4 ApS, Abacus Medicine A/S, +3 | 66 mio. kr. (samlet) | 17.2.2026 |
| Amgros 2026 1.295.a | Amgros I/S | Sciensus International B.V., Nordic Prime ApS, Orifarm A/S, 2care4 ApS, Ctruz ApS, Medartuum AB, +2 | 46,8 mio. kr. (samlet) | 29.1.2026 |
| Amgros 2026 2.1306.b | Amgros I/S | MSD Danmark ApS, EQL Pharma AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, 2care4 ApS, Abcur AB, Abacus Medicine A/S, +1 | 26 mio. kr. (samlet) | 26.1.2026 |
| Amgros 2026 1.1068.a | Amgros I/S | Orifarm A/S | 217 mio. kr. | 7.1.2026 |
| Amgros 2026 1.450.b | Amgros I/S | Orifarm A/S, Abacus Medicine A/S, Astellas Pharma A/S, 2care4 ApS, Medice Arzneimittel Pütter GmbH & Co KG | 73 mio. kr. (samlet) | 24.12.2025 |
| Amgros 2026 1.209.a | Amgros I/S | Scandinavian Biopharma Distribution, Orifarm A/S | 22,3 mio. kr. (samlet) | 12.12.2025 |
| Amgros 2026 1.1216.a | Amgros I/S | XGX Pharma ApS, Orifarm A/S | 19,8 mio. kr. (samlet) | 12.12.2025 |
| Amgros 2026 1.710.a | Amgros I/S | Orifarm A/S, Tillotts Pharma AB, Amgen Filial Af Amgen Ab Sverige | 91,2 mio. kr. (samlet) | 25.11.2025 |
| Amgros 2026 1.708.b | Amgros I/S | Zentiva Denmark ApS, Orifarm A/S, Abacus Medicine A/S, Novo Nordisk Denmark A/S, Eli Lilly Danmark A/S | 321,9 mio. kr. (samlet) | 25.11.2025 |
| Amgros 2026 1.610.a | Amgros I/S | Orifarm A/S | 75,6 mio. kr. | 13.11.2025 |
| Amgros 2026 1.1053.b | Amgros I/S | Biocon, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Denmark ApS, Pfizer ApS, Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, +2 | 948,6 mio. kr. (samlet) | 12.11.2025 |
| Amgros 2026 1.1201.a | Amgros I/S | 2care4 ApS, Macure Pharma ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Unimedic Pharma AB, Navamedic AB, +7 | 358,5 mio. kr. (samlet) | 10.11.2025 |
| Amgros 2026 2.1390.b | Amgros I/S | Viatris ApS, EQL Pharma AB, Orifarm Generics A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, +6 | 23,9 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 2.1302.b | Amgros I/S | Panpharma Nordic AS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, EQL Pharma AB, Sandoz A/S, Navamedic AB, Abcur AB, +7 | 162 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 2.1303.b | Amgros I/S | Paranova Danmark A/S, Orifarm A/S, 2care4 Generics ApS, EQL Pharma AB, Viatris ApS | 4,1 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 2.1301.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Navamedic AB, NordicInfu Care Danmark, FIlial af NordicInfu Care AB Sverige, Krka Sverige AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, +1 | 39,8 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 1.1203.a | Amgros I/S | LEO Pharma A/S, Mundipharma A/S, Pharmanovia A/S, Øresund Pharma ApS, Orifarm Generics A/S, Paranova Danmark A/S, +5 | 368,5 mio. kr. (samlet) | 30.10.2025 |